עבריתShow more about :SearchFront > NewsFrontNewsViewsFeaturesReal estateIsrael resourcesMarket pricesEventsServicesRSSNewslettersAdvertisingAboutNewsHong Kong health department recalls Teva drugThe Allopurinol tablets, reportedly produced by Teva's Hungarian plant, are used to treat hyperuricaemia and gout.16 January 12 17:47, Inbal OmerTweetHong Kong's Department of Health today ordered a recall of a batch of Allopurinol tablets made by Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA), after black substances were found on some tablets in two blisters of the product. Allopurinol is used to treat hyperuricaemia and gout.According to the Hong Kong distributor, International Medical Co. Ltd., the tablets are made by Teva Pharmaceutical Works Private Ltd Co. in Hungary.An investigation by the Department of Health found no fungal elements, and that the black substances, which adhered on the surfaces of some tablets, bear similar features as used in hydrocarbon oil. It added that the substances might be a quality issue. The Department of Health has received no reports about adverse events related to the product, but advised patients to examine the tablets before taking them.A total of 22,965 boxes had been imported into Hong Kong and were supplied to the Health Authority, local pharmacies and private doctors.Department of Health spokesman said, "In this instance, contravention of the Public Health and Municipal Services Ordinance, selling drugs not of the nature, substance or quality demanded by the purchaser, might have occurred. The maximum penalty involved is $10,000 and three months imprisonment."Published by Globes [online], Israel business news - www.globes-online.com - on January 16, 2012© Copyright of Globes Publisher Itonut (1983) Ltd. 2012Next article : Brodet postpones deadline for Leumi CEO candidatesSave articleSend to a friendPrint articleDigg it!dell.icio.usredditFacebookstumbleuponYahoo!ResponsesSubjectNameDatePrevious Home Back to top NextVIEWSShlomi CohenNova's year of transitionNova Measuring Instruments has learned to manage market expectations, which will be vital as it gears up to serve next generation chip production.Tali TsiporiComverse dividend is admission of failureA dividend in kind is usually made on a once-great asset that is unwanted and has a grim future.Batya FeldmanVC fails to tempt Israeli financial institutionsDespite the incentives, local institutions are not taking the bait, and it's not surprising.MOST POPULARTodayWeekMonthMARKET PRICESStocks and bondsTel Aviv market reportTel Aviv Stock ExchangeIsraeli stocks in NYArbitrage gaps for dual-listed stocksIsraeli stocks in EuropeIsraeli stocks on other marketsTel Aviv 25 optionsMutual fundsExchange ratesCurrent representative shekel ratesHistorical representative shekel ratesBank shekel ratesShekel/dollar optionsPrice indicesMonthly indicesAnnual movementsMarket prices|Newsletters|About us|Support|Advertise|עברית|Front|News|Views|Features|Real estate|Israel resources|International© Globes.All rights reserved.